2004
DOI: 10.1016/j.febslet.2004.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo

Abstract: CCL15 is a novel human CC chemokine and exerts its biological activities on immune cells through CCR1 and CCR3. Because a number of chemokines induce angiogenesis and endothelial cells express CCR1 and CCR3, we investigated the angiogenic activity of CCL15. Both CCL15(1-92) and Nterminal truncated CCL15(25-92) stimulate the chemotactic endothelial cell migration and differentiation, but CCL15(25-92) is at least 100-fold more potent than CCL15(1-92). Treatment with pertussis toxin (PTX), with anti-CCR1, or with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
50
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 72 publications
(53 citation statements)
references
References 26 publications
2
50
1
Order By: Relevance
“…Consistent with this upregulation of fibrogenic factors, the SPRY1 gene, an antagonist of FGFs, was significantly reduced in Th22 cells. A potential role for Th22 in remodeling or repair of the epithelial barrier is further supported by the chemokine expression pattern characterized by CCL7, involved in tissue fibrosis (39), and CCL15 and possibly CCL23 splice variant 2, both implicated in angiogenesis (40,41). We note that results with CCL23 splice variant 1 contradicted this finding ( Figure 4C), but earlier publications did not clarify which isoform was detected.…”
Section: Figurecontrasting
confidence: 56%
“…Consistent with this upregulation of fibrogenic factors, the SPRY1 gene, an antagonist of FGFs, was significantly reduced in Th22 cells. A potential role for Th22 in remodeling or repair of the epithelial barrier is further supported by the chemokine expression pattern characterized by CCL7, involved in tissue fibrosis (39), and CCL15 and possibly CCL23 splice variant 2, both implicated in angiogenesis (40,41). We note that results with CCL23 splice variant 1 contradicted this finding ( Figure 4C), but earlier publications did not clarify which isoform was detected.…”
Section: Figurecontrasting
confidence: 56%
“…Concomitant down-regulation of the Mn chemoattractants CCL2 and CCL8 and of their receptors CCR2 and CCR5 (2) was in fact observed in response to hypoxia. Similarly, we found down-regulation of CCL15, a chemoattractant for neutrophils, monocytes, and lymphocytes (76), and CCL23, a chemokine mediating resting T cell and Mn chemotaxis (77), and of their common receptor CCR1. Collectively, these data indicate that a dynamic change in chemokine/receptor expression profile occurs in Mn within hypoxic tissues.…”
Section: Discussionmentioning
confidence: 76%
“…One milliliter control medium (DMEM 5% FCS) containing recombinant human growth factors or cytokines MIP-1d, MIP-3a, IGFBP-2, or PDGF-BB (20 ng/mL, all from Peprotech), angiogenin (Novoprotein) (100 ng/mL), inhibitor PD98059 (50 mM), or conditioned medium were added in the lower compartment. Neutralizing antibodies against human MIP1d (R&D Systems) (10 mg/mL) [47] and MIP-3a (Peprotech) (10 mg/mL) [48] as well as control IgG were used. After 18 h of migration, cells were fixed with methanol at -20°C for 2 min.…”
Section: Cell Migration Assaysmentioning
confidence: 99%